OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

AES CORP. DL-01/  US00130H1059  /

Quotrix
2024-10-07  3:39:27 PM Chg. -0.3400 Volume Bid7:50:47 PM Ask7:50:47 PM Market Capitalization Dividend Y. P/E Ratio
17.1860EUR -1.94% 100
Turnover: 1,718.6000		 16.8480Bid Size: 1,960 17.0260Ask Size: 1,960 12.07 bill.EUR - -
Newsfile Corp 10-05 LBank Exchange Will List WIBE (Wibegram) on October 6
Newsfile Corp 09-19 Perseverance Metals Discovers New Nickel Zone, Yields 1.82% NiEq over 5.1 Meters at Lac Gayot Projec...
Newsfile Corp 09-17 Endurance Announces First 2024 Drill Results At The Reliance Gold Project, BC; Initial Six Holes Exp...
Newsfile Corp 09-05 Amex annonce une estimation des ressources minérales sur le projet Perron
GlobeNewswire 09-01 Li Auto Inc. August 2024 Delivery Update
GlobeNewswire 08-30 IO Biotech Updates on Pivotal Phase 3 Trial of IO102-IO103 in Combination with KEYTRUDA® (pembrolizu...
GlobeNewswire 08-28 Orchard Therapeutics Announces Multiple Presentations from across its Late-stage Neurometabolic Port...
Newsfile Corp 08-26 ALX Resources Corp. Completes Prospecting and Sampling Programs at the Cannon Copper Project, Ontari...
GlobeNewswire 08-22 Cognition Therapeutics Publishes EEG Findings from Phase 2 SEQUEL Study of CT1812 in Mild-to-Moderat...
Newsfile Corp 08-20 Appia Confirms Outstanding Desorption Results From Its Ionic Adsorption Clay Targets Maia, Electra, ...
GlobeNewswire 08-15 Great Place To Work® Announces the 2024 Best Workplaces in Latin America Representing 3.8 Million Em...
GlobeNewswire 08-15 Zealand Pharma Announces Financial Results for the First Half of 2024
GlobeNewswire 08-14 Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic...
GlobeNewswire 08-14 Unicycive Announces Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08-12 TitanFile Announces Integrations with Microsoft and NetDocuments
GlobeNewswire 08-12 Avalyn Announces Initiation of Phase 1b Clinical Study for AP02, its Novel Inhaled Nintedanib
GlobeNewswire 08-12 Plus Therapeutics Presents Positive Interim ReSPECT-LM Phase 1 Data for Leptomeningeal Metastases at...
GlobeNewswire 08-08 BOXX Workstations Feature New AMD Ryzen™ 9000 Series Processors
GlobeNewswire 08-08 Apellis and Sobi Announce Positive Topline Results from Phase 3 VALIANT Study of Pegcetacoplan in C3...
GlobeNewswire 08-07 Velocity appoints ICON exec Rachael Buck Ph.D. as Head of U.K.
GlobeNewswire 08-06 Paperclip Partners With Flying Cloud Technology, Premier Federal to Create Zero Trust Data Safe Plat...
GlobeNewswire 08-01 PRISM MarketView Launches AI Infrastructure and Datacenter Index
GlobeNewswire 08-01 Agios Announces Results from Phase 3 ACTIVATE-KidsT Study of Mitapivat in Children with PK Deficienc...
Newsfile Corp 07-30 Canter Resources Reports up to 840 ppm Lithium and 4,700 ppm Boron from Phase I Drilling at the Colu...
GlobeNewswire 07-25 BioAtla Highlighted Clinical Program and Pipeline Updates at Virtual R&D Day